Champions Oncology (CSBR) vs Neumora Therapeutics (NMRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Champions Oncology (CSBR) has outperformed Neumora Therapeutics (NMRA) over the past year, losing 25.4% versus a loss of 74.8%. Neumora Therapeutics is the larger company by market cap ($86.0 million vs $68.1 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CSBR | NMRA |
|---|---|---|
| Share price | $4.90 | $0.4579 |
| Market cap | $68.13M | $86.04M |
| 1-day change | +0.31% | -2.21% |
| YTD return | -29.38% | -73.84% |
| 1-year return | -25.38% | -74.82% |
| 5-year return | -51.59% | — |
| Forward P/E | 48.95 | — |
| EPS (TTM) | $-0.07 | $-1.23 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.31 | $3.65 |
| 52-week low | $4.59 | $0.451 |
| Distance from 52-week high | -41.10% | -87.45% |
| Average volume | 11.50K | 1.18M |
| Shares outstanding | 13.92M | 187.90M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CSBR has outperformed NMRA by 49.4 percentage points over the past year.
CSBR vs NMRA FAQ
Which is bigger, Champions Oncology or Neumora Therapeutics?
Neumora Therapeutics (NMRA) is larger, with a market capitalization of $86.04M compared with $68.13M for Champions Oncology (CSBR).
Which stock has performed better over the past year, CSBR or NMRA?
CSBR returned -25.38% over the past 12 months, compared with -74.82% for NMRA (price return, excluding dividends). Past performance does not predict future results.
Are Champions Oncology and Neumora Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.